LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 8 of total 8

Search options

  1. Article ; Online: Intestines-erythrocytes-mediated bio-disposition deciphers the hypolipidemic effect of berberine from Rhizoma Coptidis: A neglected insight.

    Huang, Ziwei / Li, Minhua / Qin, Zehui / Ma, Xingdong / Huang, Ronglei / Liu, Yuhong / Xie, Jianhui / Zeng, Huifang / Zhan, Ruoting / Su, Ziren

    Journal of ethnopharmacology

    2023  Volume 314, Page(s) 116600

    Abstract: Ethnopharmacological relevance: Rhizoma Coptidis (RC), the dried rhizome of Coptis Chinensis Franch., can dispel dampness and heat within the body and has been traditionally used for the treatment of cardiovascular disease (CVD)-associated problems ... ...

    Abstract Ethnopharmacological relevance: Rhizoma Coptidis (RC), the dried rhizome of Coptis Chinensis Franch., can dispel dampness and heat within the body and has been traditionally used for the treatment of cardiovascular disease (CVD)-associated problems including hyperlipidemia in China. Berberine (BBR) is the main active component of RC, which has been shown to possess significant therapeutic potential. However, only 0.14% of BBR is metabolized in the liver, and the extremely low bioavailability (<1%) and blood concentration of BBR in experimental and clinical settings is insufficient to achieve the effects as observed under in vitro conditions, which imposes challenges to explain its excellent pharmacological actions. Intense efforts are currently being devoted to defining its specific pharmacological molecular targets, while the exploration from the perspective of its pharmacokinetic disposition has rarely been reported to date, which could hardly make a comprehensive understanding of its hypolipidemic enigma.
    Aim of the study: This study made a pioneering endeavor to unveil the hypolipidemic mechanism of BBR from RC focusing on its unique intestines-erythrocytes-mediated bio-disposition.
    Materials and methods: The fate of BBR in intestines and erythrocytes was probed by a rapid and sensitive LC/MS-IT-TOF method. To analyze the disposition of BBR, a reliable HPLC method was subsequently developed and validated for simultaneous determination of BBR and its key active metabolite oxyberberine (OBB) in whole blood, tissues, and excreta. Meanwhile, the enterohepatic circulation (BDC) of BBR and OBB was verified by bile duct catheterization rats. Finally, lipid overloading models of L02 and HepG2 cells were employed to probe the lipid-lowering activity of BBR and OBB at in vivo concentration.
    Results: The results showed that BBR underwent biotransformation in both intestines and erythrocytes, and converted into the major metabolite oxyberberine (OBB). The AUC
    Conclusions: Cumulatively, BBR underwent unique extrahepatic metabolism and disposition into OBB by virtue of intestines and erythrocytes. BBR and OBB were mainly presented and transported in the protein-bound form within the circulating erythrocytes, potentially resulting in hepatocyte targeting accompanied by obvious enterohepatic circulation. The unique extrahepatic disposition of BBR via intestines and erythrocytes conceivably contributed enormously to its hypolipidemic effect. OBB was the important material basis for the hypolipidemic effect of BBR and RC.
    MeSH term(s) Rats ; Animals ; Berberine/pharmacology ; Berberine/therapeutic use ; Plant Extracts/pharmacology ; Triglycerides/metabolism ; Intestines ; Erythrocytes/metabolism
    Chemical Substances Berberine (0I8Y3P32UF) ; Plant Extracts ; Triglycerides
    Language English
    Publishing date 2023-05-15
    Publishing country Ireland
    Document type Journal Article
    ZDB-ID 134511-4
    ISSN 1872-7573 ; 0378-8741
    ISSN (online) 1872-7573
    ISSN 0378-8741
    DOI 10.1016/j.jep.2023.116600
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Intestines-erythrocytes-mediated bio-disposition deciphers the hypolipidemic effect of berberine from Rhizoma Coptidis: A neglected insight

    Huang, Ziwei / Li, Minhua / Qin, Zehui / Ma, Xingdong / Huang, Ronglei / Liu, Yuhong / Xie, Jianhui / Zeng, Huifang / Zhan, Ruoting / Su, Ziren

    Journal of Ethnopharmacology. 2023 Oct., v. 314 p.116600-

    2023  

    Abstract: Rhizoma Coptidis (RC), the dried rhizome of Coptis Chinensis Franch., can dispel dampness and heat within the body and has been traditionally used for the treatment of cardiovascular disease (CVD)-associated problems including hyperlipidemia in China. ... ...

    Abstract Rhizoma Coptidis (RC), the dried rhizome of Coptis Chinensis Franch., can dispel dampness and heat within the body and has been traditionally used for the treatment of cardiovascular disease (CVD)-associated problems including hyperlipidemia in China. Berberine (BBR) is the main active component of RC, which has been shown to possess significant therapeutic potential. However, only 0.14% of BBR is metabolized in the liver, and the extremely low bioavailability (<1%) and blood concentration of BBR in experimental and clinical settings is insufficient to achieve the effects as observed under in vitro conditions, which imposes challenges to explain its excellent pharmacological actions. Intense efforts are currently being devoted to defining its specific pharmacological molecular targets, while the exploration from the perspective of its pharmacokinetic disposition has rarely been reported to date, which could hardly make a comprehensive understanding of its hypolipidemic enigma. This study made a pioneering endeavor to unveil the hypolipidemic mechanism of BBR from RC focusing on its unique intestines-erythrocytes-mediated bio-disposition. The fate of BBR in intestines and erythrocytes was probed by a rapid and sensitive LC/MS-IT-TOF method. To analyze the disposition of BBR, a reliable HPLC method was subsequently developed and validated for simultaneous determination of BBR and its key active metabolite oxyberberine (OBB) in whole blood, tissues, and excreta. Meanwhile, the enterohepatic circulation (BDC) of BBR and OBB was verified by bile duct catheterization rats. Finally, lipid overloading models of L02 and HepG2 cells were employed to probe the lipid-lowering activity of BBR and OBB at in vivo concentration. The results showed that BBR underwent biotransformation in both intestines and erythrocytes, and converted into the major metabolite oxyberberine (OBB). The AUC₀₋ₜ ratio of total BBR to OBB was approximately 2:1 after oral administration. Besides, the AUC₀₋ₜ ratio of bound BBR to its unbound counterpart was 4.6:1, and this ratio of OBB was 2.5:1, indicative of abundant binding-type form in the blood. Liver dominated over other organs in tissue distribution. BBR was excreted in bile, while the excretion of OBB in feces was significantly higher than that in bile. Furthermore, the bimodal phenomenon of both BBR and OBB disappeared in BDC rats and the AUC₀₋ₜ was significantly lower than that in the sham-operated control rats. Interestingly, OBB significantly decreased triglycerides and cholesterol levels in lipid overloading models of L02 and HepG2 cells at in vivo-like concentration, which was superior to the prodrug BBR. Cumulatively, BBR underwent unique extrahepatic metabolism and disposition into OBB by virtue of intestines and erythrocytes. BBR and OBB were mainly presented and transported in the protein-bound form within the circulating erythrocytes, potentially resulting in hepatocyte targeting accompanied by obvious enterohepatic circulation. The unique extrahepatic disposition of BBR via intestines and erythrocytes conceivably contributed enormously to its hypolipidemic effect. OBB was the important material basis for the hypolipidemic effect of BBR and RC.
    Keywords Coptis chinensis ; berberine ; bile ; bile ducts ; bioavailability ; biotransformation ; cardiovascular diseases ; catheters ; cholesterol ; erythrocytes ; excretion ; feces ; heat ; hyperlipidemia ; lipemic effect ; liver ; metabolites ; oral administration ; pharmacokinetics ; rhizomes ; tissue distribution ; traditional medicine ; China ; Extrahepatic metabolism ; Intestine microflora ; Erythrocyte ; Oxyberberine ; Hypolipidemic ; AST ; ALT ; BBR ; BDC ; BSA ; CD ; EHC ; FFAs ; HCl ; IS ; OA ; OBB ; PA ; TFA ; TG
    Language English
    Dates of publication 2023-10
    Publishing place Elsevier B.V.
    Document type Article ; Online
    ZDB-ID 134511-4
    ISSN 1872-7573 ; 0378-8741
    ISSN (online) 1872-7573
    ISSN 0378-8741
    DOI 10.1016/j.jep.2023.116600
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  3. Article ; Online: Hypouricemic and nephroprotective effects of palmatine from Cortex Phellodendri Amurensis: A uric acid modulator targeting Keap1-Nrf2/NLRP3 axis.

    Ai, Gaoxiang / Huang, Ronglei / Xie, Jianhui / Zhong, Linjiang / Wu, Xiaoyan / Qin, Zehui / Su, Ziren / Chen, Jiannan / Yang, Xiaobo / Dou, Yaoxing

    Journal of ethnopharmacology

    2022  Volume 301, Page(s) 115775

    Abstract: Ethnopharmacological relevance: Palmatine (Pal) is a major bioactive alkaloid originated from ancient Chinese herbal medicine Cortex Phellodendri Amurensis (CPA), which has long been applied to treat hyperuricemia (HUA)-related diseases. Pal possesses ... ...

    Abstract Ethnopharmacological relevance: Palmatine (Pal) is a major bioactive alkaloid originated from ancient Chinese herbal medicine Cortex Phellodendri Amurensis (CPA), which has long been applied to treat hyperuricemia (HUA)-related diseases. Pal possesses potent anti-inflammatory and anti-oxidant effects against metabolic diseases. However, its potential beneficial effect against PO (potassium oxonate)/HX (hypoxanthine)-induced HUA remains elusive.
    Aim of the study: This study aimed to investigate the potential pharmacological effect and mechanism of Pal on PO/HX-induced HUA in mice.
    Material and methods: A mouse model of HUA was established by co-administration of PO/HX once daily for 7 consecutive days. The HUA mice were orally given three doses (25, 50 and 100 mg/kg) of Pal daily for a week. Febuxostat (Feb, 5 mg/kg) was given as a positive control. At the scheduled termination of the experiment, the whole blood, liver and kidney were collected for subsequent analyses. The concentrations of uric acid (UA), creatinine (CRE) and blood urea nitrogen (BUN), and activities of adenosine deaminase (ADA) and xanthine oxidase (XOD) were evaluated. Histopathological alterations of the kidney were detected by H&E staining. The inflammatory and oxidative stress status was detected by assay kits. Additionally, key proteins involved in the urate transporter, Keap1-Nrf2 and TXNIP/NLRP3 signaling pathways were evaluated by immunohistochemistry and Western blotting. Finally, molecular docking was employed to probe the binding characteristics of Pal and target proteins Keap1, NLRP3, URAT1 and HO-1.
    Results: Administration of Pal substantially decreased the elevated kidney weight, lowered UA, CRE and BUN levels, and attenuated abnormal histopathological alterations. Meanwhile, treatment with Pal also dramatically lowered hepatic XOD and ADA activities. Besides, Pal treatment effectively mitigated the renal inflammatory and oxidative stress markers. Further mechanistic investigation indicated Pal distinctly downregulated the protein levels of GLUT9 and URAT1, while up-regulated the expression levels of OAT1 and ABCG2. Pal also restored Nrf2 activation, promoted subsequent expression of anti-oxidative enzymes, and downregulated the expressions of TXNIP, NLRP3, apoptosis-associated speck-like (ASC), caspase-1, IL-1β and IL-18. Molecular docking analysis also indicated Pal firmly bound with Keap1, NLRP3, URAT1 and HO-1.
    Conclusions: These findings indicated that Pal exhibited favorable anti-HUA effect via modulating the expressions of transporter-related proteins and suppressing XOD activity. Furthermore, Pal also alleviated HUA-induced kidney injury, which was at least partially related to restoring Keap1-Nrf2 pathway and inhibiting TXNIP/NLRP3 inflammasome. Our investigation was envisaged to provide experimental support for the traditional application of CPA and CPA-containing classical herbal formulas in the management of HUA-related diseases and might provide novel dimension to the clinical application of Pal.
    MeSH term(s) Mice ; Animals ; Uric Acid ; NLR Family, Pyrin Domain-Containing 3 Protein/metabolism ; Kelch-Like ECH-Associated Protein 1/metabolism ; NF-E2-Related Factor 2/metabolism ; Molecular Docking Simulation ; Hyperuricemia/chemically induced ; Hyperuricemia/drug therapy ; Hyperuricemia/metabolism ; Xanthine Oxidase/metabolism ; Kidney ; Creatinine
    Chemical Substances Uric Acid (268B43MJ25) ; NLR Family, Pyrin Domain-Containing 3 Protein ; Kelch-Like ECH-Associated Protein 1 ; palmatine (G50C034217) ; NF-E2-Related Factor 2 ; Xanthine Oxidase (EC 1.17.3.2) ; Creatinine (AYI8EX34EU) ; Keap1 protein, mouse ; Nlrp3 protein, mouse
    Language English
    Publishing date 2022-10-02
    Publishing country Ireland
    Document type Journal Article
    ZDB-ID 134511-4
    ISSN 1872-7573 ; 0378-8741
    ISSN (online) 1872-7573
    ISSN 0378-8741
    DOI 10.1016/j.jep.2022.115775
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Self-Assembled nanoparticles Combining Berberine and Sodium Taurocholate for Enhanced Anti-Hyperuricemia Effect.

    Qin, Zehui / Li, Minhua / Cheng, Juanjuan / Huang, Ziwei / Ai, Gaoxiang / Qu, Chang / Xie, Youliang / Li, Yucui / Liao, Huijun / Xie, Jianhui / Su, Ziren

    International journal of nanomedicine

    2023  Volume 18, Page(s) 4101–4120

    Abstract: Propose: Berberine (BBR) is extensively studied as an outstanding anti-hyperuricemia drug. However, the clinical application of BBR was limited due to its poor absorption and low bioavailability. Therefore, there is an urgent necessity to find a novel ... ...

    Abstract Propose: Berberine (BBR) is extensively studied as an outstanding anti-hyperuricemia drug. However, the clinical application of BBR was limited due to its poor absorption and low bioavailability. Therefore, there is an urgent necessity to find a novel drug formulation to address the issues of BBR in clinical application.
    Methods: Herein, we conducted the solubility, characterization experiments to verify whether BBR and sodium taurocholate (STC) self-assembled nanoparticles (STC@BBR-SANPs) could form. Furthermore, we proceeded the release experiment in vitro and in vivo to investigate the drug release effect. Finally, we explored the therapeutic effect of STC@BBR-SANPs on hyperuricemia (HUA) through morphological observation of organs and measurement of related indicators.
    Results: The solubility, particle size, scanning electron microscopy (SEM), and stability studies showed that the stable STC@BBR-SANPs could be formed in the BBR-STC system at ratio of 1:4. Meanwhile, the tissue distribution experiments revealed that the STC@BBR-SANPs could accelerate the absorption and distribution of BBR. In addition, the pharmacology study demonstrated that both BBR and STC@BBR-SANPs exhibited favorable anti-HUA effects and nephroprotective effects, while STC@BBR-SANPs showed better therapeutic action than that of BBR.
    Conclusion: This work indicated that STC@BBR-SANPs can be self-assembly formed, and exerts excellent uric acid-lowering effect. STC@BBR-SANPs can help to solve the problems of poor solubility and low absorption rate of BBR in clinical use, and provide a new perspective for the future development of BBR.
    MeSH term(s) Berberine/pharmacology ; Taurocholic Acid ; Nanoparticles ; Drug Liberation ; Solubility
    Chemical Substances Berberine (0I8Y3P32UF) ; Taurocholic Acid (5E090O0G3Z)
    Language English
    Publishing date 2023-07-26
    Publishing country New Zealand
    Document type Journal Article
    ZDB-ID 2364941-0
    ISSN 1178-2013 ; 1176-9114
    ISSN (online) 1178-2013
    ISSN 1176-9114
    DOI 10.2147/IJN.S409513
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: [Comparative Study on Effects of Anti-Gastritis,Gastric Mucosal Protection and Gastrointestinal Movement Promotion of Root and Stem of Zanthoxylum nitidum].

    Qin, Ze-hui / Chen, Wei-xuan / Li, Ru-liu / Han, Zheng-zhou / Yang, Tie-chui / Zhan, Ruo-ting / Chen, Wei-wen

    Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials

    2018  Volume 39, Issue 1, Page(s) 164–169

    Abstract: Objective: To provide the experimental evidence for expansion of medicinal parts of Zanthoxylum nitidum by comparing the effects of anti-gastritis,gastric mucosal protection and gastrointestinal movement promotion of its root and stem.: Methods: The ... ...

    Abstract Objective: To provide the experimental evidence for expansion of medicinal parts of Zanthoxylum nitidum by comparing the effects of anti-gastritis,gastric mucosal protection and gastrointestinal movement promotion of its root and stem.
    Methods: The pharmacological effects between root and stem of Zanthoxylum nitidum were compared by observing the anti-gastritis effect on rats with chronic superficial gastritis induced by iodoacetamide, evaluating the gastric mucosal protective effect on rats’ gastric ulcer induced by stress, indometacin and pylorus ligation test, and investigating gastrointestinal movement promotion effect on mice gastric evacuation and intestinal propelling.
    Results: Both root and stem of Zanthoxylum nitidum showed effects of relieving the inflammation symptoms of rats’ gastric mucosa induced by iodoacetamide, gastric ulcer respectively induced by stress, and presenting a strong inhibition of free acid and pepsin activity in gastric juice. Furthermore stem parts of Zanthoxylum nitidum in promoting gastrointestinal motility even showed better efficacy than root.
    Conclusion: Stem of Zanthoxylum nitidum has similar effects of anti-gastritis, gastric mucosal protection and gastrointestinal movement promotion with root of Zanthoxylum nitidum.
    MeSH term(s) Animals ; Gastric Juice ; Gastric Mucosa ; Gastritis ; Inflammation ; Mice ; Plant Roots ; Plant Stems ; Rats ; Stomach Ulcer ; Zanthoxylum
    Language Chinese
    Publishing date 2018-08-06
    Publishing country China
    Document type Comparative Study ; Journal Article
    ISSN 1001-4454
    ISSN 1001-4454
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Effect of the serum of rats treated with Suo Quan pill on embryonic stem cells.

    Xu, Jing-Jing / Huang, Ping / Xiang, Yun-Ya / Tan, Bo / Wu, Qing-He / Qin, Ze-Hui / Cao, Hong-Ying

    Pakistan journal of pharmaceutical sciences

    2018  Volume 31, Issue 1(Suppl.), Page(s) 263–268

    Abstract: Suo Quan pill(SQP), a well-known and classical traditional Chinese medicine compound, consists of three traditional Chinese medicine: Alpinia oxyphylla Miq., Lindera aggregata (Sims) Kosterm., Dioscorea opposite. Its effect was summarized as ... ...

    Abstract Suo Quan pill(SQP), a well-known and classical traditional Chinese medicine compound, consists of three traditional Chinese medicine: Alpinia oxyphylla Miq., Lindera aggregata (Sims) Kosterm., Dioscorea opposite. Its effect was summarized as supplementing kidney-yang and shrinkaging urination. This study evaluated the effects of the serum of rats treated with Suo Quan pill on embryonic stem cells(ES cells). Cell proliferation was detected by MTT assay. Cell cycle and apoptosis of ES cells were evaluated with flow cytometry. Nanog mRNA expression was verified by fluorescence quantitative PCR and Nanog protein in ES cells was determined by Western blot. The serum of SQP-treated rats not only promoted ES cells proliferation and Nanog expression in ES cells, but also inhibited H202 stimulated cell apoptosis. Furthermore, the serum of rats containing SQP affected the cell cycle distribution of ES cells, reducing the percentage of cells in G0/G1phase and increasing the percentage of cells in G2/M phase, increasing the proliferation index of ES cells. These results illustrate that the enhanced effect of SQP on ES cells proliferation is in part due to the increased expression of Nanog in ES cells, the accelerated cell cycle period and the inhibited apoptosis of ES cells.
    MeSH term(s) Animals ; Apoptosis/drug effects ; Cell Cycle/drug effects ; Cell Proliferation/drug effects ; Cells, Cultured ; Drugs, Chinese Herbal/pharmacology ; Embryonic Stem Cells/drug effects ; Embryonic Stem Cells/metabolism ; Male ; Mice ; Nanog Homeobox Protein/genetics ; Nanog Homeobox Protein/metabolism ; Rats, Sprague-Dawley ; Serum
    Chemical Substances Drugs, Chinese Herbal ; Nanog Homeobox Protein ; Nanog protein, mouse
    Language English
    Publishing date 2018-02-01
    Publishing country Pakistan
    Document type Journal Article
    ZDB-ID 885131-1
    ISSN 1011-601X
    ISSN 1011-601X
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: [Comparative Study on Effects of Anti-contusion Injury, Analgesia and Anti-inflammation of Root and Stem of Zanthoxylum nitidum].

    Chen, Wei-xuan / Qin, Ze-hui / Zeng, Dan / Han, Zheng-zhou / Zhan, Ruo-ting / Tan, Ying / Chen, Wei-wen

    Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials

    2015  Volume 38, Issue 11, Page(s) 2358–2363

    Abstract: Objective: To provide the scientific evidence for expansion of medicinal parts of Zanthoxylum nitidum by comparing the effects of anti-contusion injury, analgesia and anti-inflammation of its root and stem.: Methods: The pharmacological effects ... ...

    Abstract Objective: To provide the scientific evidence for expansion of medicinal parts of Zanthoxylum nitidum by comparing the effects of anti-contusion injury, analgesia and anti-inflammation of its root and stem.
    Methods: The pharmacological effects between root and stem of Zanthoxylum nitidum were compared by observing the anti-injury effect in rats with injury struck by hammer. The analgesic effect in mice was evaluated by writhing test and hot plate test, and the anti-inflammatory effect on paw edema induced by carrageenan and granuloma induced by cotton pellet were investigated in rats.
    Results: Both root and stem of Zanthoxylum nitidum relieved the exterior and histological symptoms of rats' injury legs struck by hammer, decreased the numbers of mice's writhing, enhanced pain threshold of mice on heat plate, inhibited the edema of rats induced by carrageenan, and suppressed the granuloma of rats induced by cotton pellet.
    Conclusion: Stem of Zanthoxylum nitidum has similar effects of anti-contusion injury, analgesia and anti-inflammation with root of Zanthoxylum nitidum.
    MeSH term(s) Analgesics/pharmacology ; Animals ; Anti-Inflammatory Agents/pharmacology ; Carrageenan ; Contusions/drug therapy ; Edema/chemically induced ; Edema/drug therapy ; Inflammation/drug therapy ; Mice ; Pain/drug therapy ; Pain Threshold ; Plant Extracts/pharmacology ; Plant Roots/chemistry ; Plant Stems/chemistry ; Rats ; Zanthoxylum/chemistry
    Chemical Substances Analgesics ; Anti-Inflammatory Agents ; Plant Extracts ; Carrageenan (9000-07-1)
    Language Chinese
    Publishing date 2015-11
    Publishing country China
    Document type Comparative Study ; English Abstract ; Journal Article
    ISSN 1001-4454
    ISSN 1001-4454
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: [Study of pharmacokinetics of nicotine in local brain by using microdialysis and stable labeled isotope].

    Wu, Xiu-Jun / Ling, Jia-Jun / Fu, Xiang / Qin, Ze-Hui / Zhang, Ying-Feng

    Yao xue xue bao = Acta pharmaceutica Sinica

    2011  Volume 46, Issue 3, Page(s) 333–337

    Abstract: The paper is to report the study of pharmacokinetics of transdermal administered nicotine in the brain of freely moving rat by using microdialysis with stable labeled isotope as internal standard. The pharmacokinetic behavior of nicotine in Sprague ... ...

    Abstract The paper is to report the study of pharmacokinetics of transdermal administered nicotine in the brain of freely moving rat by using microdialysis with stable labeled isotope as internal standard. The pharmacokinetic behavior of nicotine in Sprague Dawley rat brain was investigated after intranasal administration (3.75 mg). Brain fluid samples were collected by intracerebral microdialysis with DL-nicotine as internal standard. Concentrations of nicotine and DL-nicotine in the sample were measured by HPLC-MS/MS. Main pharmacokinetic parameters were calculated and analyzed by Das 2.0 pharmacokinetic software. The recovery of nicotine and the delivery of DL-nicotine were the same. The fate of absorption and distribution was two compartment model and the values of t1/2alpha was 170.31 min, t1/2beta was 263.30 min and the AUC(0-infinity) was 2.75 x 10(5) microg x L(-1) min separately. DL-nicotine can be used to calibrate the recovery of nicotine, and the new method of stable isotope microdialysis can be used to study the pharmacokinetics of freely moving rat. It will make sense for the treatment of addiction of tobacco and provide a new thought for the research of pharmacokinetics-pharmacodynamic combination.
    MeSH term(s) Administration, Cutaneous ; Administration, Intranasal ; Animals ; Area Under Curve ; Brain/metabolism ; Chromatography, High Pressure Liquid ; Deuterium ; Female ; Isotope Labeling/methods ; Male ; Microdialysis/methods ; Nicotine/administration & dosage ; Nicotine/pharmacokinetics ; Rats ; Rats, Sprague-Dawley ; Tandem Mass Spectrometry
    Chemical Substances Nicotine (6M3C89ZY6R) ; Deuterium (AR09D82C7G)
    Language Chinese
    Publishing date 2011-03
    Publishing country China
    Document type English Abstract ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 788758-9
    ISSN 0513-4870
    ISSN 0513-4870
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top